Skip to main content

Market Overview

Drug Supply Disruption: Amazon, Walmart Reportedly Vying For Online Pharmacy PillPack

Drug Supply Disruption: Amazon, Walmart Reportedly Vying For Online Pharmacy PillPack

Walmart Inc (NYSE: WMT) reportedly wants to acquire online pharmacy PillPack but could have one notable obstacle in its way: competition from, Inc. (NASDAQ: AMZN).

The Analyst

Bernstein health care services analyst Lance Wilkes.

The Thesis

PillPack is an online pharmacy that delivers prescription drugs to customers and was founded in 2013, Wilkes said in a research report. The company is backed by multiple venture capital firms; it was valued at $330 million in 2016 and could be sold to either Walmart or Amazon for under $1 billion, the analyst said. 

Walmart and Amazon both have similar low margin, market share first strategies, so an acquisition by either company will "negatively impact" the entire drug supply sector's margins, Wilkes said.

On Walmart's end, an acquisition of the online pharmacy would be consistent with its health care and pharmacy space business, with a particular focus on seniors. PillPack's value proposition targets seniors with multiple prescriptions, and Humana Inc (NYSE: HUM), a close Walmart partner, is also a leading MA MCO.

On the other hand, interest from Amazon in PillPack would be consistent with its desire to enter and disrupt the pharmacy market.

Price Action

Walmart shares were nearly flat at the time of publication, while Amazon's stock was lower by 1.65 percent. 

Related Links:

Walmart's Reported Talks With Humana 'Fairly Unsurprising,' Says BMO

Cramer: Here's Why Centene Is A Buy Amid Amazon's Health Care Push

Latest Ratings for AMZN

Feb 2021CitigroupMaintainsBuy
Feb 2021UBSMaintainsBuy
Feb 2021BenchmarkMaintainsBuy

View More Analyst Ratings for AMZN
View the Latest Analyst Ratings


Related Articles (AMZN + WMT)

View Comments and Join the Discussion!

Posted-In: Bernstein Lance WilkesAnalyst Color M&A News Health Care Analyst Ratings General Best of Benzinga

Latest Ratings

FSRMorgan StanleyMaintains40.0
MEDDA DavidsonMaintains302.0
VICRBWS FinancialMaintains120.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at